| Serum Galactomannan and (1->3) β-D-Glucan Assays in Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia. | |
| | |
MedLine Citation:
|
PMID: 22170932 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
We assessed the performance of galactomannan and (1→3)-β-D-glucan in 29 serum samples from patients with multiple myeloma and Waldenstrom's macroglobulinemia without invasive fungal disease to address issues of false positivity and uninterpretable results previously reported among patients with these conditions. Galactomannan and (1→3)-β-D-glucan assays were not falsely elevated in any patient. (1→3)-β-D-glucan assay results were uninterpretable in 24% of patients. Patients with IgG >2000 mg/dL had higher odds of uninterpretable (1→3)-β-D-glucan results. |
| | |
Authors:
|
Nicolas C Issa; Sophia Koo; Robert C Lynch; Charline Gay; Sarah P Hammond; Lindsey R Baden; Irene M Ghobrial; Malcolm A Finkelman; Francisco M Marty |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-14 |
Journal Detail:
|
Title: Journal of clinical microbiology Volume: - ISSN: 1098-660X ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7505564 Medline TA: J Clin Microbiol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The population structure of multi- and extensively drug-resistant tuberculosis in South Africa.
Next Document: The International Circumpolar Surveillance Interlaboratory Quality Control Program for Serotyping Ha...